healthy

Documents about healthy

• 7 U.S.C. § 6953 — Healthy food financing initiative#560255US Code (LII)
• 7 U.S.C. § 3179 — Research on strategies to promote the selection and consumption of healthy foods#560798US Code (LII)
• 7 U.S.C. § 2026a — Healthy fluid milk incentives projects#561217US Code (LII)
• 15 U.S.C. § 2695 — Grants for healthy school environments#566182US Code (LII)
• 16 U.S.C. § 6571 — Establishment of healthy forests reserve program#568174US Code (LII)
• 42 U.S.C. § 300u-14 — Healthy aging, living well; evaluation of community-based prevention and wellness programs for Medicare beneficiaries#594736US Code (LII)
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants#18532ClinicalTrials.gov
• Metformin ER 750 mg Tablets, Fed#18533ClinicalTrials.gov
• Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants#18537ClinicalTrials.gov
• Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects#18549ClinicalTrials.gov
• Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg#18562ClinicalTrials.gov
• GLS-5700 in Dengue Virus-Naïve Adults#18688ClinicalTrials.gov
• The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Immune Function and Inflammatory Conditions - a Randomized Placebo-controlled Double-blinded Intervention Trial#28381ClinicalTrials.gov
• A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes#28532ClinicalTrials.gov
• Drug Concentration of Metformin According to Sampling Method#28547ClinicalTrials.gov
• A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions#28558ClinicalTrials.gov
• Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg#28566ClinicalTrials.gov
• Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil#67666ClinicalTrials.gov
• BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.#67815ClinicalTrials.gov
• Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)#67819ClinicalTrials.gov
• A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants#67831ClinicalTrials.gov
• Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.#67847ClinicalTrials.gov
• Antibacterial Effect of NaOCl With Etidronic Acid in Apical Periodontitis Treatment#67935ClinicalTrials.gov
• Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly#121229ClinicalTrials.gov
• Mediterranean Diet and Mushrooms#121247ClinicalTrials.gov
• A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers#121285ClinicalTrials.gov
• Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.#121303ClinicalTrials.gov
• Experimental Ebola Vaccine Trial#121433ClinicalTrials.gov
• Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects#123398ClinicalTrials.gov
• A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body#123413ClinicalTrials.gov
• In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme#123431ClinicalTrials.gov
• Bioavailability of Human Milk Oligosaccharides in Healthy Adults#123492ClinicalTrials.gov
• Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine#123535ClinicalTrials.gov
• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.#123559ClinicalTrials.gov
• Assessing Neurovisual Function in Patients With Cognitive Impairment#123616ClinicalTrials.gov
• Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).#329441ClinicalTrials.gov
• Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)#332713ClinicalTrials.gov
• Clinical Trial to Compare the Pharmacokinetics and Pharmacodynamics After Oral Administration of Glucophage and HL-018#332721ClinicalTrials.gov
• Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe#332796ClinicalTrials.gov
• An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults#332805ClinicalTrials.gov
• Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl#343741ClinicalTrials.gov
• Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg#346899ClinicalTrials.gov
• Effect of Nutrition Labeling on Fast Food Choices#349886ClinicalTrials.gov
• Effect of Omeprazole on Metformin#349917ClinicalTrials.gov
• Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fasting Conditions#349918ClinicalTrials.gov
• Understanding the Persistence of Immunity After MenC Vaccines#349997ClinicalTrials.gov
• To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh#350004ClinicalTrials.gov
• Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use#353328ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health#353338ClinicalTrials.gov
• Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers#356531ClinicalTrials.gov

Related topics